Results 241 to 250 of about 4,614,031 (312)

Integrating artificial intelligence and manual curation to enhance bioassay annotations in ChEMBL. [PDF]

open access: yesJ Cheminform
Smit I   +8 more
europepmc   +1 more source

Establishment of a humanized patient‐derived xenograft mouse model of high‐grade serous ovarian cancer for preclinical evaluation of combination immunotherapy

open access: yesMolecular Oncology, EarlyView.
We have established a humanized orthotopic patient‐derived xenograft (Hu‐oPDX) mouse model of high‐grade serous ovarian cancer (HGSOC) that recapitulates human tumor–immune interactions. Using combined anti‐PD‐L1/anti‐CD73 immunotherapy, we demonstrate the model's improved biological relevance and enhanced translational value for preclinical ...
Luka Tandaric   +10 more
wiley   +1 more source

Hippo pathway at the crossroads of stemness and therapeutic resistance in breast cancer

open access: yesMolecular Oncology, EarlyView.
Dysregulation of the Hippo pathway drives nuclear accumulation of YAP/TAZ, activating stemness‐related transcriptional programs that sustain breast cancer stemness and fuel therapeutic resistance across subtypes, underscoring Hippo signaling as a targetable vulnerability. Figure created and edited with BioRender.com.
Giulia Schiavoni   +11 more
wiley   +1 more source

Lack of harmonisation in immunological data: challenges in synthesising data during the COVID-19 pandemic. [PDF]

open access: yesEBioMedicine
Shaver N   +11 more
europepmc   +1 more source

IL40: A Newly Described Cytokine With Conflicting Measurements and Detection Variability-Are There Different Forms? [PDF]

open access: yesScand J Immunol
Euler N   +9 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy